Received Mar 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 553J7 | — |
administration of an expired Engerix-B dose to an infant; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-week-old male patient who received HBV (Engerix B) (batch number 553J7, expiry date 28-MAR-2025) for prophylaxis. On 26-DEC-2025, the patient received Engerix B. On 26-DEC-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: administration of an expired Engerix-B dose to an infant). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-MAR-2026 The reporter asked whether there had been any adverse reactions.